Small actions can create such huge differences. We see that butterfly effect playing out in Latin America. where the development of a new generation of crops using CRISPR and other new breeding techniques (NBTs) is now unfolding and whats smaller than a gene?
Changes in a single gene are revolutionizing science, making a big impact on medicine and agriculture: think COVID vaccines or genes that increase yield or climate resilience or nutritional value of crops. In the food sector, gene-edited tomatoes, wheat and other foods are already being consumed and commercialized, and dozens more are on the way.
The main challenge going forward in the agriculture sector, particularly in Latin America, is how NBTs will be regulated. As GMOs in which genes are moved between species to introduce specific traits? Transgenic techniques are heavily regulated in most jurisdictions because of the presence of so-called foreign genes.
Many of the innovation-blocking regulations were composed in the early 2000s when much less was known about genes, and fear and misunderstanding drove public opinion against the science, and politicians followed suit.
Scientists believe the obsession of distinguishing between what is natural and what is a foreign gene is scientifically silly, as even in nature genes flow from one species to another. This dubious notion has long throttled the biotech ag revolution.
If this is the regulatory model going forward, the CRISPR ag revolution will stall. Gene editingwhich is known as cisgenicscan introduce many new traits but is not a substitute in many cases for transgenicsdoes not involve moving genes among species.
The EU, at least for now, seems intent on sticking to the backward GMO regulations it adopted in 2001 and 2003 in the wake of food scares unrelated to biotechnology. The United States, Canada, China, Japan, and even the United Kingdom are shedding decade-old superstitions and taking steps to greenlight gene editing.
Latin American nations are also taking global leadership in the research and development of gene-edited crops. Argentina, Brazil, and other South American countries are being proactive, creating regulatory frameworks that will make these novel crops accessible to farmers and consumers in just a few years time. They will be evaluated as conventional crops, making the research and development process needed for environmental release and testing affordable to developers something that does not happen with transgenic GMOs in which only big companies can afford to run the expensive, time-consuming regulatory gauntlet.
The relatively minuscule costs necessary to bring new products to the evaluation stage could help unleash an entrepreneurial revolution in the food sector, ironically undercutting the influence of multinational agribusinesses. This regulatory revolution could reshape the publics perception of genetically modified crops and knee-cap aggressive anti-biotech activist groups that have spent decades spreading alarmist, unfounded fears that multinational corporations are out to control the global food supply.
In Latin America, agricultural biotechnology public research centers are popping up, allocating resources to develop novel crop varieties. New and small companies are being founded and funded. Together they are revolutionizing the future of food production in Latin America, with crops and foods being developed from a farmers and consumers perspective and by creating novel crop varieties with regional interest.
In Argentina, BioHeuris, an expert in weed management, is leading the synthetic biology revolution, working with CRISPR tools to develop next-generation herbicide-resistant soybean, sorghum, alfalfa, rice, and cotton. Created in 2016, BioHeuris accelerates plant breeding to evolve crops faster than weeds. Together with integrated pest management techniques, they expect to develop a sustainable system for numerous crops with varieties available for commercialization by 2026 or 2027.
With our platforms fully operational, time to market will be reduced by half and development costs cut 100 times compared to current GMO crops developed by the big seed companies, said co-founder and Director of Strategy Carlos Perez.
CONABIA, Argentinas biosafety commission, has already ruled that these gene-edited plants should not be regulated as GMOs. In January, APHIS in the United States and Brazils CTNBio (National Technical Biosafety Commission) also gave the green light for the introduction of BioHeuris CRISPR solution.
In Brazil, the government-funded company Embrapa is emerging as an innovation leader in exploiting. It developed the first gene-edited sugarcane in the world. It has two varieties: one offers higher cell wall digestibility and a higher concentration of sucrose in plant tissues. CTNBio has determined that neither variety will be regulated as a transgenic GMO.
According to the deputy head of Research and Development at Embrapa, the development of new cultivars through CRISPR is at the frontier of knowledge.
These cultivars are only the beginning, and they pave the way for the development and delivery of other cultivars for the production sector with characteristics that will directly impact the productivity and reduce production costs.
Colombia is following a different path. CIAT (International Center for Tropical Agriculture), a public research center, has been identified as a pioneer in genome editing in Colombia and is leading the national research and development of gene-edited crops. CIATs researchers have worked on several crops including cassava, rice, and beans. The modified rice variety is resistant to the hoja blanca virus, a disease that bleaches the leaves off and eventually kills rice plants. It is prevalent in Latin America. CIATs team is also exploring the use of genome editing to make it easier for people to digest beans.
Chiles research team is based in the Department of Biology of Sciences Faculty at the University of Chile. It is working on creating gene-edited crops, focusing on tomatoes and kiwi that can tolerate drought and soil salinity. In addition, they are using CRISPR to modify apples to increase their nutritional profile, adding a higher content of carotenoids, and resisting the oxidation that causes browning after they are cut.
In addition to the efforts made by the University of Chile, NeoCrop, an emerging company, is joining them in the domestic research landscape of gene-edited crops. They are developing gene-edited wheat that produces higher levels of fiber and is resistant to drought and extreme heat. NeoCrop expects to have this new gene-edited wheat variety ready for field trials this year or next.
This emerging dynamic offers a preview of the future in which small and entrepreneurial start-ups will lead in the research and development of novel crops with a focus on farmers and consumers. Increasingly, NGO criticism that crop biotechnology in Latin America is being driven by monopolistic corporations is obsolete and misguided.
Luis Ventura is a trained biologist and biosafety expert. Luis is a member of Mexican Scientist Allies for Knowledge in Agriculture and a 2016 Alliance for Science Global Leadership Fellow and trainer. View Luis LinkedIn pagehere. Find Luis on Twitter@Iuisventura
See the original post:
- IOM not webcast today. Why Not? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- National Academies skeptical at Best. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Some Confusion Exists [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Why DTC Genomics IS Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- First Mari, Now Linda. Who's next? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Is it true? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Re-Reviewing the National Academies [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- The problem with nonclinicians....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Crazy Night of Emails to Government [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Adrienne Carlson's Personalized Medicine. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Tell Me, How do you feel now? Sherpa's RX [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- This Just In. 23andMe to go to GPs. I love my readers!! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Sorry so long away [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- 2D6 Rears its ugly head..... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Ok, Fine, Back to Plavix [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Kaiser a protoype for Collins' Aim [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- A few months late to the party.... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Stated Another Way....... [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Excuse Me? Harvard and Navigenics? WTF? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Follow up to Yesterday's WTF? Harvard, Navi? and Pfizer??? [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Did you get your kit? Thanks Dr. Rob from MedCo [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Gluco...Wha? Parkinson's Disease and Glucocerebrosidase mutations. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Away and now back, What did I miss???? 23andme layoffs? Selling Genomes for cheap up next! [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Change IS Needed. I agree with William, sometimes. [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Good Enough Science? Apparently so at 23andme [Last Updated On: November 8th, 2009] [Originally Added On: November 8th, 2009]
- Long QT Syndrome, location matters [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Congratulations Generation Health. Nice pick up! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- An argument 23andSerge can't win...23andme but not medicine [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Stop. Breathe. Repeat. An analysis of the direction of DTC Genomics Field. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Hey DTC genomics, Stay Private, Stay Alive, Go Public and Die [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- You can't have it both way. Either scared your genome is sold off or not. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- 15 Days Away Gives Time for Perspective. [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- What about the SACGHS registry? Another missed opportunity? [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- AJHG is in and my Favorite Muin is in it! But He Is NOT the Father! [Last Updated On: December 13th, 2009] [Originally Added On: December 13th, 2009]
- Navigenics for 23andMe prices? [Last Updated On: December 18th, 2009] [Originally Added On: December 18th, 2009]
- Lp(a) Maybe there's something there that wasn't there before? [Last Updated On: December 24th, 2009] [Originally Added On: December 24th, 2009]
- Another Year, Another Bankruptcy [Last Updated On: December 31st, 2009] [Originally Added On: December 31st, 2009]
- 5 Technologies going bye bye in this decade? [Last Updated On: January 6th, 2010] [Originally Added On: January 6th, 2010]
- Hackers, HITECH and HIPAA in DTC Genomics, Oh My! [Last Updated On: January 7th, 2010] [Originally Added On: January 7th, 2010]
- Personal Genomics Flop.....big Belly Flop! [Last Updated On: January 8th, 2010] [Originally Added On: January 8th, 2010]
- Gotta Love It. Even the daycare....... [Last Updated On: January 11th, 2010] [Originally Added On: January 11th, 2010]
- Congratulations Navigenics. You ARE a clinical lab! Uh-Oh... [Last Updated On: January 12th, 2010] [Originally Added On: January 12th, 2010]
- CETP, Jewish Centenarians and Alzheimers [Last Updated On: January 14th, 2010] [Originally Added On: January 14th, 2010]
- Enter the "Not" DTC Genomics Rep [Last Updated On: January 17th, 2010] [Originally Added On: January 17th, 2010]
- Why Dr. Vanier's Navigenics appointment is good for PM [Last Updated On: January 22nd, 2010] [Originally Added On: January 22nd, 2010]
- Holy Crap! MedCo Follows in CVS footsteps [Last Updated On: February 3rd, 2010] [Originally Added On: February 3rd, 2010]
- FDA, Warfarin, still not as sexy to me. [Last Updated On: February 5th, 2010] [Originally Added On: February 5th, 2010]
- Hype, Hype, Hype from a single study. [Last Updated On: February 11th, 2010] [Originally Added On: February 11th, 2010]
- I love my readers, even Renata M! [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- How can insurers use DTC genomics to profile? [Last Updated On: February 17th, 2010] [Originally Added On: February 17th, 2010]
- 9p21.....ahem. Paynter et.al. Smackdown. Again. [Last Updated On: February 18th, 2010] [Originally Added On: February 18th, 2010]
- Hey! It's Pete Hulick! Are you Going to GET? [Last Updated On: February 19th, 2010] [Originally Added On: February 19th, 2010]
- I was wrong......AHEM [Last Updated On: February 28th, 2010] [Originally Added On: February 28th, 2010]
- G2C2, finally a tool for genomic education! [Last Updated On: March 2nd, 2010] [Originally Added On: March 2nd, 2010]
- Just 4 million? What 23andMe is worth. [Last Updated On: March 5th, 2010] [Originally Added On: March 5th, 2010]
- What a difference a year makes [Last Updated On: March 9th, 2010] [Originally Added On: March 9th, 2010]
- ........DTC Genomic Medicine? [Last Updated On: March 12th, 2010] [Originally Added On: March 12th, 2010]
- The FDA, 2c19 and the ACC [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- The problem with Comparative Whole Genomics...... [Last Updated On: March 13th, 2010] [Originally Added On: March 13th, 2010]
- BRCA testing by 23andME is the same as Myriad Genetics. [Last Updated On: March 15th, 2010] [Originally Added On: March 15th, 2010]
- The Argument Against DTC Genomics Marketing and such [Last Updated On: March 16th, 2010] [Originally Added On: March 16th, 2010]
- A moment of Clarity. Some DTCG is not bad. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- SNPs for breast cancer risk? It Depends. [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- How can MDVIP use Navigenics Test for Medicine? [Last Updated On: March 18th, 2010] [Originally Added On: March 18th, 2010]
- Why did P&G invest in Navigenics? [Last Updated On: March 23rd, 2010] [Originally Added On: March 23rd, 2010]
- PGx in DTCG? Doesn't stand up to Useful testing. [Last Updated On: March 25th, 2010] [Originally Added On: March 25th, 2010]
- End of Gene Patents? [Last Updated On: March 29th, 2010] [Originally Added On: March 29th, 2010]
- Sherpa Accepting Chief Medical Officership [Last Updated On: April 3rd, 2010] [Originally Added On: April 3rd, 2010]
- The Rumors of My Death........ [Last Updated On: April 20th, 2010] [Originally Added On: April 20th, 2010]
- Happy DNA Day! [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 99 USD, DNA day and patient letters [Last Updated On: April 25th, 2010] [Originally Added On: April 25th, 2010]
- 2C19, Navigenics and Clinical Reality. [Last Updated On: May 1st, 2010] [Originally Added On: May 1st, 2010]
- Coriell Personalized Medicine Collaborative rising [Last Updated On: May 7th, 2010] [Originally Added On: May 7th, 2010]
- Personal Genomes in Clinical Care. Quake paper is a waste! [Last Updated On: May 11th, 2010] [Originally Added On: May 11th, 2010]
- Personal Genomes in Clinical Care. Quake paper Falls Short! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- Last post edited by Drew [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? FCUK U! [Last Updated On: May 13th, 2010] [Originally Added On: May 13th, 2010]
- GateKeeper? F! U! [Last Updated On: May 15th, 2010] [Originally Added On: May 15th, 2010]
- Potential of genomic medicine, LOST [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- How Bad Can a House Investigation be for DTC Genomics? [Last Updated On: May 20th, 2010] [Originally Added On: May 20th, 2010]